Montreal, Canada

Elizabeth Wong

This inventor holds 2 USPTO granted patents. Top assignee: Merck Frosst Canada, Inc.. Active years: 1996-2007.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Location History:

  • Montreal, CA (1996)
  • St. Laurent, CA (2007)

Company Filing History:


Years Active: 1996-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Elizabeth Wong

Introduction

Elizabeth Wong is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of biotechnology, particularly in the study of cyclooxygenase enzymes. With a total of 2 patents to her name, her work has implications for medical research and therapeutic development.

Latest Patents

Wong's latest patents include innovations related to human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity. The first patent discloses a human cyclooxygenase-2 cDNA, which allows for the preferential and independent measurement of cyclooxygenase-2 or cyclooxygenase-1 activity present in a given sample. This invention is crucial for understanding the role of these enzymes in various biological processes and diseases.

Career Highlights

Elizabeth Wong is currently employed at Merck Frosst Canada, Inc., where she continues to advance her research in the field. Her work has garnered attention for its potential applications in drug development and disease treatment.

Collaborations

Wong has collaborated with esteemed colleagues such as Brian P. Kennedy and Wanda A. Cromlish. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in her area of expertise.

Conclusion

Elizabeth Wong's contributions to biotechnology through her patents and research at Merck Frosst Canada, Inc. highlight her role as an influential inventor in the field. Her work continues to pave the way for future innovations in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…